Skip to main content

Nanostream Gets $22M Series C Financing

NEW YORK, June 4 - Pasadena, Calif.-based Nanostream, a microfluidics developer, today announced $22 million in Series C funding.


The company said the round was lead by AEA Investors -- a New York firm created in 1969 to invest funds of the Rockefellers, Mellons and Harrimans -- and Lilly BioVentures, the venture capital arm of Eli Lilly.


Other investors included: Techno Venture Management of Munich, Germany, and Flagship Ventures of Cambridge, Mass., as well as private investors who had participated in previous funding rounds of $11 million.


Founded in 1999, the company manufactures a system of instruments, microfluidics cartridges, and software.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.